share_log

3: Initial statement of beneficial ownership of securities-Director Neuman John

3: Initial statement of beneficial ownership of securities-Director Neuman John

3：首次持股聲明-董事 Neuman John
美股SEC公告 ·  06/14 16:28
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corp's director and 10% owner, John Neuman, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The document, dated June 5, 2024, indicates that Neuman does not beneficially own any non-derivative or derivative securities of the company. The filing, which is a routine disclosure for individuals in Neuman's position, was completed on June 14, 2024. This formality is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting by directors, officers, and principal shareholders of public companies.
SeaStar Medical Holding Corp's director and 10% owner, John Neuman, has filed an initial statement of beneficial ownership with the SEC, as per Form 3 requirements. The document, dated June 5, 2024, indicates that Neuman does not beneficially own any non-derivative or derivative securities of the company. The filing, which is a routine disclosure for individuals in Neuman's position, was completed on June 14, 2024. This formality is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934, which mandates reporting by directors, officers, and principal shareholders of public companies.
SeaStar Medical Holding Corp的董事和10％股東John Neuman根據Form 3的要求向SEC提交了一份初步受益所有權聲明。這份文件日期爲2024年6月5日，表明Neuman沒有實質性擁有該公司的任何非衍生或衍生證券。在2024年6月14日完成的報告中，這是Neuman所在位置個人的例行披露。此程序是《1934年證券交易法》第16(a)條規定的監管合規的一部分，規定公共公司的董事，高管和重要股東必須報告。
SeaStar Medical Holding Corp的董事和10％股東John Neuman根據Form 3的要求向SEC提交了一份初步受益所有權聲明。這份文件日期爲2024年6月5日，表明Neuman沒有實質性擁有該公司的任何非衍生或衍生證券。在2024年6月14日完成的報告中，這是Neuman所在位置個人的例行披露。此程序是《1934年證券交易法》第16(a)條規定的監管合規的一部分，規定公共公司的董事，高管和重要股東必須報告。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息